Strategic product development engagement with Capgemini to support product design, engineering architecture, manufacturing readiness, and commercialization planning
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) ("Illumisoft" or the "Company") is developing its SaniLux 216 nanometre far ultraviolet C ("far UVC") disinfection platform to enable the safe mitigation of airborne pathogen risk in high-occupancy indoor environments where people live, work, learn, travel, and gather. Today, the Company announced that it is taking steps to accelerate the platform's development.
To support the path to market for SaniLux, Illumisoft has entered into a strategic product development engagement with Capgemini to advance product development, industrial design, engineering architecture, manufacturing readiness, and commercialization planning for the platform.
Capgemini is a global AI-powered business and technology transformation partner with operations across more than fifty countries and a worldwide team of approximately 420,000 team members. frog and Synapse, part of Capgemini, will carry out the engagement, bringing deep experience in innovation strategy, product design, connected technology engineering, manufacturing readiness, and new product commercialization. Through this engagement, Capgemini will work alongside Illumisoft's technical leadership to help advance SaniLux from its current technology development stage toward a designed, engineered, and manufacturable commercial product family for priority built environment applications.
Management Commentary
"Airborne pathogen risk remains a meaningful challenge across healthcare, transportation, education, hospitality, commercial real estate, and other high occupancy indoor environments," said Ehsan Agahi, Executive Chair of Illumisoft. "SaniLux is being developed to address that problem by enabling a potential continuous use far UVC disinfection platform for occupied spaces. Our objective is to turn SaniLux from a promising technology platform into a scalable and safe commercial product family for sectors where indoor air quality, infection prevention, and operational continuity matter most. Working with Capgemini supports our efforts to advance the platform toward commercialization by complementing our semiconductor and lighting expertise with product design, engineering, manufacturing readiness, and commercialization capabilities."
Capgemini Commentary
"Far UVC has transformative potential for human health and well-being, aligning closely with frog's mission to better the human experience. We are proud to support Illumisoft in shaping and bringing this technology into the spaces where people live and work," said Ryan Starling, Head of Industrial Design, West Coast, frog, part of Capgemini.